The latest discoveries related to breast cancer research, diagnosis and treatment will be presented by several of the nation's most highly esteemed breast cancer specialists at a day-long symposium at the University of California San Francisco, Thursday, April 30, from 9:00 a.m. to 5:15 p.m., at Cole Hall on the UCSF campus.
Researchers will present up-to-date results regarding new breast cancer diagnostic techniques; the genetics of breast cancer and what it means for prevention, diagnosis and treatment; and changing trends in breast cancer incidence and mortality, including the role of diet, hormones and environment. In addition, researchers and patient advocates will describe the increasingly important role that patient advocates are playing in developing research and treatment programs and in improving treatment outcomes for cancer patients.
The symposium is sponsored by the UCSF Cancer Center, directed by Frank McCormick, PhD, the David A. Wood Professor of Tumor Biology and Cancer Research. The goal of the UCSF Cancer Center is to become the first NCI-designated comprehensive cancer center in Northern California. UCSF expects to apply for the designation this year.
Speakers at the UCSF Cancer Center's day-long symposium include: Virginia Ernster, PhD, UCSF professor of epidemiology and biostatistics at UCSF, will provide an overview on the latest demographic trends in breast cancer incidence and mortality. Ernster also will discuss risk factors for breast cancer, including lifestyle, hormonal, and environmental factors; possible preventive strategies; and the pros and cons of mammography screening.
Ernster, who along with her colleagues has described an "epidemic of
diagnosis" of a type of breast cancer called ductal carcinoma in situ, leads a
large National Cancer Institute (NCI)-funded project to establish a computerized
population-based mammography registry for San Francisco that will be linked to
Contact: Jeffrey Norris
University of California - San Francisco